Finance

Beta
Lists
4579:TYO
RaQualia Pharma Inc
¥490.00
+2.94%
(+14.00) 1D
Jun 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4579...
Open
¥471
High
¥498
Low
¥469
Mkt. cap
12.76B
Avg. vol.
266.63K
Volume
274.60K
P/E ratio
1,337.66
52-wk high
¥1,465
52-wk low
¥469
EPS
¥0
Shares outstanding
20.39M
No. of employees
85
Open
¥471
High
¥498
Low
¥469
Mkt. cap
12.76B
Avg. vol.
266.63K
Volume
274.60K
P/E ratio
1,337.66
52-wk high
¥1,465
52-wk low
¥469
EPS
¥0
Shares outstanding
20.39M
No. of employees
85
News stories
From sources across the web
About RaQualia Pharma Inc
CEO-
Employees85
FoundedFeb 19, 2008
Headquarters-
SectorPharmaceutical industry
Websiteraqualia.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
569.59M
775.05M
1.67B
801.00M
Cost of goods sold
166.66M
158.07M
164.78M
181.00M
Cost of revenue
166.66M
158.07M
164.78M
181.00M
Research and development expenses
396.94M
454.60M
362.13M
477.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
290.11M
316.93M
21.32M
304.00M
Operating expense
687.04M
771.53M
675.45M
781.00M
Total operating expenses
853.70M
929.60M
840.23M
962.00M
Operating income
-284.11M
-154.55M
827.74M
-161.00M
Other non operating income
-23.93M
11.07M
-34.76M
-10.00M
EBT including unusual items
-320.22M
-135.24M
863.66M
-159.00M
EBT excluding unusual items
-351.22M
-135.24M
837.66M
-148.00M
Income tax expense
28.56M
78.99M
21.68M
66.00M
Effective tax rate
-8.92%
-58.41%
2.51%
-41.51%
Other operating expenses
-
-
-
-
Net income
-348.78M
-214.24M
841.98M
-225.00M
Net profit margin
-61.23%
-27.64%
50.48%
-28.09%
Earnings per share
-
-
-
-
Interest and investment income
3.84M
5.64M
11.40M
15.00M
Interest expense
-15.53M
-14.75M
-14.07M
-15.00M
Net interest expenses
-11.69M
-9.10M
-2.67M
-
Depreciation and amortization charges
-
-
7.00M
-
EBITDA
-165.96M
-33.70M
956.64M
-51.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer